(MoneyNewsWire.Net, October 16, 2020 ) Australia ranked seventh in the world for the prevalence of type 1 diabetes in children and 6th highest for incidence. There is also rising prevalence of particularly type 2 diabetes and rising cases of children and adolescents who are now impated by type 2 diabetes in Australia. Type 1diabetes typically happens in an early age, its a most common form of childhood diabetes although it can occur at any age. Over 1 million Australians have been diagnosed with diabetes. Australia is dragging behind many western countries in providing affordable access to its people with diabetes to new, proven technologies such as CGM and Insulin pen that can significantly improve the management of diabetes. Australia Diabetes Market is expected to reach USD 2.44 Billion by the year 2025.
The market of Self Monitoring Blood Glucose Device, Continuous Glucose Monitoring (CGM) Device, Insulin Pump, and Insulin Pen are growing due to the rising awareness for diabetes in Australia. Diabetes care in Australia has reached a high level of quality, but there is still an opportunity for further improvement. Diabetes is associated with an uncountable of complications that affect the eyes, feet, kidneys, and cardiovascular health. Besides, diabetes is ranked in the top 10 leading causes of deaths in Australia. Diabetes is a massive challenge to the nation’s health and economy.
Australian Government has essential roles in maintaining access to affordable, high-quality devices and services to support people with diabetes in self-management and treatment. The Australian Government providing support to people with diabetes through the National Diabetes Services Scheme, the Pharmaceutical Benefits Scheme, the Insulin Pump Program, and Medicare. In 2019, Biocon and Mylan N V launched insulin glargine biosimilar Semglee, first insulin PBS in Australia. In 2019, TAL, a leading Australian life insurance specialist, has launched a specialized product to protect people with diabetes mellitus in Australia.
Renub Research report titled “Australia Diabetes Market & Forecast, By Self Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement), Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pump Analysis- (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies), Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Companies (Eli Lilly and Company, B. Braun Melsungen AG, Ypsomed AG, Artsana S.p.A, BD, Novo Nordisk A/S, Medtronic, Insulet Corporation, Owen Mumford Ltd, LifeScan Inc., Dexcom Inc, Abbott Laboratories and Roche)” provides a complete analysis of Australia Insulin Delivery Devices Market.
Request a free Sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=australia-diabetes-market-p.php
Segments Market based on Devices
# Continuous Glucose Monitoring (CGM)
# Self Monitoring Blood Glucose (SMBG)
# Insulin Pen
# Insulin Pump
Australia Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM)
1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market
1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 14 Companies Studied in the Report have been Studied from 3 Points
• Company Overview
• Recent Developments
• Financial Insight
1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
5. Novo Nordisk A/S
6. Owen Mumford Ltd
7. Ypsomed AG
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories
13. Dexcom Inc
Key Benefits of the Report
• This report provides current market estimates and forecasts for Australia Diabetic Market.
• Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
• Australia Diabetic Market – Growth Drivers and Challenges.
• Key sustainability strategies adopted by market players.
Industry Related Opportunity:
United States Diabetes Market: https://www.renub.com/united-states-diabetes-market-p.php
Germany Diabetes Market: https://www.renub.com/germany-diabetes-market-p.php
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Follow on Linkedin: https://www.linkedin.com/company/renub-research
Market Research, Bus